12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Florbetapir regulatory update

Eli Lilly said FDA granted Priority Review to an NDA for florbetapir for use in PET imaging of beta amyloid aggregates in the brain to...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >